NPPA and cardiac hypertrophy: Pathological cardiac hypertrophy is characterized by the enhancement of cardiomyocytes, reconfiguration of cardiac structure, and elevated expression of atrial natriuretic peptide (ANP) and brain natriuretic peptide (BNP) (1, 2).